Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial

被引:0
作者
Nampota-Nkomba, Nginache [1 ]
Nyirenda, Osward M. [1 ]
Khonde, Lameck [1 ]
Mapemba, Victoria [1 ]
Mbewe, Maurice [2 ]
Ndaferankhande, John M. [2 ]
Msuku, Harrison [2 ]
Masesa, Clemens [2 ]
Misiri, Theresa [2 ]
Mwakiseghile, Felistas [2 ]
Patel, Priyanka D. [2 ]
Patel, Pratiksha [2 ]
Johnson-Mayo, Ifayet [3 ]
Pasetti, Marcela F. [3 ]
Heyderman, Robert S. [2 ,4 ]
Tracy, J. Kathleen [3 ]
Datta, Shrimati [3 ]
Liang, Yuanyuan [3 ]
Neuzil, Kathleen M. [3 ]
Gordon, Melita A. [2 ,5 ]
Laurens, Matthew B. [3 ]
机构
[1] Kamuzu Univ Hlth Sci, Blantyre Malaria Project, Blantyre, Malawi
[2] Kamuzu Univ Hlth Sci, Malawi Liverpool Welkome Trust Clin Res Programme, Blantyre, Malawi
[3] Univ Maryland, Ctr Vaccine Dev & Global Hlth, Sch Med, Baltimore, MD 21201 USA
[4] UCL, Dept Infect, Div Infect Dis, London, England
[5] Univ Liverpool, Liverpool, Merseyside, England
来源
LANCET GLOBAL HEALTH | 2022年 / 10卷 / 09期
基金
比尔及梅琳达.盖茨基金会;
关键词
ENTERIC FEVER; EFFICACY; MEASLES; MULTICENTER; INFANTS;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Typhoid fever is a substantial public health problem in Africa, yet there are few clinical trials of typhoid conjugate vaccine (TCV). We assessed immunogenicity and safety of Typbar TCV in Malawi. Methods This substudy was nested within a phase 3, double-blind, parallel design, randomised controlled trial of TCV in children from Ndirande Health Centre in Ndirande township, Blantyre, Malawi. To be eligible, participants had to be aged between 9 months and 12 years with no known immunosuppression or chronic health conditions, including HIV or severe malnutrition; eligible participants were enrolled into three strata of approximately 200 children (9-11 months, 1-5 years, and 6-12 years), randomly assigned (1:1) to receive TCV or control (meningococcal serogroup A conjugate vaccine [MCV-A]) intramuscularly. Serum was collected before vaccination and at 28 days and 730-1035 days after vaccination to measure anti-Vi antibodies by ELISA. Because of COVID-19, day 730 visits were extended up to 1035 days. This nested substudy evaluated reactogenicity, safety, and immunogenicity by age stratum. Safety outcomes, analysed in the intention-to-treat population, included solicited adverse events within 7 days of vaccination (assessed on 3 separate days) and unsolicited adverse events within 28 days of vaccination. This trial is registered with ClinicalTrials.gov , NCT03299426. Findings Between Feb 22 and Sept 6,2018,664 participants were screened, and 631 participants were enrolled and randomly assigned (320 to the TCV group and 311 to the MCV-A group). 305 participants in the TCV group and 297 participants in the MCV-A group were vaccinated. Among TCV recipients, anti-Vi IgG geometric mean titres increased more than 500 times from 4.2 ELISA units (EU)/mL (95% CI 4.0-4.4) at baseline to 2383.7 EU/mL (2087.2-2722.3) at day 28, then decreased to 48.0 EU/mL (39.9-57.8) at day 730-1035, remaining more than 11 times higher than baseline. Among MCV-A recipients, anti-Vi IgG titres remained unchanged: 4.3 EU/mL (4.0-4.5) at baseline, 4.4 EU/mL (4. 0-4.7) on day 28, and 4.6 EU/mL (4.2-5.0) on day 730-1035. TCV and MCV-A recipients had similar solicited local (eight [3%] of 304, 95% CI 1.3-5.1 and three [1%] of 293, 0.4-3.0) and systemic (27 [9%] of 304, 6.2-12.6 and 27 [W] of 293, 6.4-13.1) reactogenicity. Related unsolicited adverse events occurred similarly in TCV and MCV-A recipients in eight (3%) of 304 (1.3-5.1) and eight (3%) of 293 (1.4-5.3). Interpretation This study provides evidence of TCV safety, tolerability, and immunogenicity up to 730-1035 days in Malawian children aged 9 months to 12 years. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.
引用
收藏
页码:E1326 / E1335
页数:10
相关论文
共 30 条
  • [1] Typhoid Fever Diagnosis in Endemic Countries: A Clog in the Wheel of Progress?
    Ajibola, Olumide
    Mshelia, Mari B.
    Gulumbe, Bashar H.
    Eze, Anthonius A.
    [J]. MEDICINA-LITHUANIA, 2018, 54 (02):
  • [2] Implementation of Interventions for the Control of Typhoid Fever in Low- and Middle-Income Countries
    Barac, Raluca
    Als, Daina
    Radhakrishnan, Amruta
    Gaffey, Michelle F.
    Bhutta, Zulfiqar A.
    Barwick, Melanie
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (03) : 79 - 88
  • [3] Morbidity and Mortality of Typhoid Intestinal Perforation Among Children in Sub-Saharan Africa 1995-2019: A Scoping Review
    Birkhold, Megan
    Coulibaly, Yacaria
    Coulibaly, Oumar
    Dembele, Philadelphie
    Kim, Daniel S.
    Sow, Samba
    Neuzil, Kathleen M.
    [J]. WORLD JOURNAL OF SURGERY, 2020, 44 (09) : 2892 - 2902
  • [4] An Appraisal of the Clinical Features of Pediatric Enteric Fever: Systematic Review and Meta-analysis of the Age-Stratified Disease Occurrence
    Britto, Carl
    Pollard, Andrew J.
    Voysey, Merryn
    Blohmke, Christoph J.
    [J]. CLINICAL INFECTIOUS DISEASES, 2017, 64 (11) : 1604 - 1611
  • [5] Associations among Water, Sanitation, and Hygiene, and Food Exposures and Typhoid Fever in Case-Control Studies: A Systematic Review and Meta-Analysis
    Brockett, Sarah
    Wolfe, Marlene K.
    Hamot, Asa
    Appiah, Grace D.
    Mintz, Eric D.
    Lantagne, Daniele
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2020, 103 (03) : 1020 - 1031
  • [6] Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination
    Cohen, Bernard J.
    Audet, Susette
    Andrews, Nick
    Beeler, Judy
    [J]. VACCINE, 2007, 26 (01) : 59 - 66
  • [7] Salmonella enterica Serovar Typhi and the Pathogenesis of Typhoid Fever
    Dougan, Gordon
    Baker, Stephen
    [J]. ANNUAL REVIEW OF MICROBIOLOGY, VOL 68, 2014, 68 : 317 - +
  • [8] Occurrence of Typhoid Fever Complications and Their Relation to Duration of Illness Preceding Hospitalization: A Systematic Literature Review and Meta-analysis
    Espinoza, Ligia Maria Cruz
    McCreedy, Ellen
    Holm, Marianne
    Im, Justin
    Mogeni, Ondari D.
    Parajulee, Prerana
    Panzner, Ursula
    Park, Se Eun
    Toy, Trevor
    Haselbeck, Andrea
    Seo, Hye Jin
    Jeon, Hyon Jin
    Kim, Jong-Hoon
    Kwon, Soo Young
    Kim, Jerome H.
    Parry, Christopher M.
    Marks, Florian
    [J]. CLINICAL INFECTIOUS DISEASES, 2019, 69 : S435 - S448
  • [9] Rapid Emergence of Multidrug Resistant, H58-Lineage Salmonella Typhi in Blantyre, Malawi
    Feasey, Nicholas A.
    Gaskell, Katherine
    Wong, Vanessa
    Msefula, Chisomo
    Selemani, George
    Kumwenda, Save
    Allain, Theresa J.
    Mallewa, Jane
    Kennedy, Neil
    Bennett, Aisleen
    Nyirongo, Joram O.
    Nyondo, Patience A.
    Zulu, Madalitso D.
    Parkhill, Julian
    Dougan, Gordon
    Gordon, Melita A.
    Heyderman, Robert S.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2015, 9 (04):
  • [10] Persistence of Vaccine-Induced Measles Antibody Beyond Age 12 Months: A Comparison of Response to One and Two Doses of Edmonston-Zagreb Measles Vaccine Among HIV-Infected and Uninfected Children in Malawi
    Fowlkes, Ashley
    Witte, Desiree
    Beeler, Judy
    Audet, Susette
    Garcia, Philip
    Curns, Aaron
    Yang, Chunfu
    Fudzulani, Richard
    Broadhead, Robin
    Bellini, William J.
    Cutts, Felicity
    Helfand, Rita F.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2011, 204 : S149 - S157